Skip to content

Clinical study of Qingfei Zhisou plaster in the treatment of pneumonia in children

Clinical study of transdermal Qingfei Zhisou plaster in the treatment of pneumonia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079945
Enrollment
Unknown
Registered
2024-01-17
Start date
2022-11-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia in children

Interventions

Treatment group:Qingfei Zhisou plaster+Basic Treatment
Control group:Qingfei Zhisou Simulator+Basic Treatment

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. meeting the diagnostic criteria of Chinese and Western medicine. 2. age 1 to 13 years. 3. duration of illness <7 days. 4. signed an informed consent form and were willing to cooperate with the study.

Exclusion criteria

Exclusion criteria: 1. Combination of other primary diseases of the lung. 2. Combination of serious primary diseases of the heart, liver, kidney and hematopoietic system, psychiatric. 3. Participants in clinical trials of other drugs. 4. Patients with history of severe skin allergy or serious adverse reactions after using plaster.

Design outcomes

Primary

MeasureTime frame
Effective rate of treatment;

Secondary

MeasureTime frame
Effective rate of traditional Chinese medicine syndrome;

Countries

China

Contacts

Public ContactSiyun Jiang

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

371408818@qq.com+86 139 0161 9519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026